
Gallant's decision to leave Amikam was made after a security risk assessment conducted by the Shin Bet.
Former defense minister Yoav Gallant vacated his home in Moshav Amikam in northern Israel over a year ago, following a threat made against him shortly before the end of his term.
The decision to leave Amikam was made after a security risk assessment conducted by the Shin Bet (Israel Security Agency).
Gallant is currently renting an apartment in Tel Aviv with his wife, Israeli media reported on Friday.
The apartment was described as “luxurious,” though no additional details were provided regarding its size or other specifications.
Gallant evacuated due security threat
Sources familiar with the matter said the Shin Bet's evacuation order was issued due to the location of Gallant's home and the nature of the threat. However, they noted that the level of risk Gallant faces remains exceptionally high.
No details have ever been officially published regarding the nature of the threat or the circumstances surrounding it.
Both Gallant and his wife declined to comment on the matter.
LATEST POSTS
- 1
From Representative to Business visionary: Private issue Victories25.09.2023 - 2
Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial10.12.2025 - 3
Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push09.12.2025 - 4
Hostages as leverage: Iran's secret demand aimed at crippling Israel's agriculture04.12.2025 - 5
Culinary Joys: Investigating Connoisseur Cooking at Home01.01.1
Flash flooding causes highways to close to and from Eilat
5 Arising Professions in Environmentally friendly power
Manual for Tracking down the Mysterious Cascades in China
The Significance of Prenuptial Arrangements in Separation Procedures
Mountain Trekking on a Tight spending plan: Tracking down the Right Bicycle
The Most Paramount Crossroads in Olympic History
Manual for extravagance SUVs for seniors
Building a Maintainable Closet: Individual Excursions in Moral Style
The Craft of Computerized Detox: Individual Trials













